Mouse Secondary Antibodies
Jackson Immuno Research Labs Biotin-SP (long spacer) AffiniPure Mouse Anti-Human IgG, Fcγ fragment specific, 1ml
Biotin-SP-AffiniPure Mouse Anti-Human IgG, Fc Fragment Specific (min X Bov,Hrs,Ms Sr Prot)
Jackson Immuno Research Labs MOUSE ANTI-HUMAN IGG (H+L)
AffiniPure Mouse Anti-Human IgG (H+L) (min X Ms Sr Prot)
Jackson Immuno Research Labs MOUSE ANTI-HU IGG, HRP CONJ
Peroxidase-AffiniPure Mouse Anti-Human IgG (H+L) (min X Bov,Hrs,Ms Sr Prot)
Bio X Cell RecombiMAb Anti-Mouse PD-L1, Clone 10F.9G2-CP154, 1 MG
The 10F.9G2™-CP154 monoclonal antibody is a recombinant chimeric version of the original 10F.9G2™ antibody, with variable domain sequences identical to the original but constant region sequences switched from rat IgG2b to mouse IgG2a. This antibody contains a LALA-PG mutation in the Fc fragment, preventing it from binding to endogenous Fcγ receptors. It reacts with mouse PD-L1 (programmed death ligand 1), also known as B7-H1 or CD274, and blocks its interaction with PD-1 and B7-1 (CD80).
- Recombinant chimeric antibody
- LALA-PG mutation in Fc fragment prevents binding to endogenous Fcγ receptors
- Blocks interaction between PD-L1 and PD-1, and between PD-L1 and B7-1 (CD80)
- Purified from CHO cell supernatant in an animal-free facility
- Purity ≥95%, determined by SDS-PAGE
- Endotoxin ≤0.5 EU/mg
Biotium CA19-9/Sialyl Lewisa (GI Tumor Marker) (CA19.9/1390R), CF488A conjugate, 0.1mg/mL
CA19-9, a carbohydrate epitope expressed on a high MW (>400 kDa) mucin glycoprotein, is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group antigens. In normal tissues, sialyl Lewisa antigen is present in ductal epithelium of the breast, kidney, salivary gland, and sweat glands. Its expression is greatly enhanced in serum as well as in the majority of tumor cells in gastrointestinal (GI) carcinomas, including adenocarcinomas of the stomach, intestine, and pancreas. Preoperative elevated CA19-9 levels in patients with stage I pancreatic carcinoma decrease to normal values following surgery. When used serially, CA19-9 can predict recurrence of disease prior to radiographic or clinical findings. This MAb is excellent for staining of formalin-fixed, paraffin-embedded tissues.Primary antibodies are available purified, or with a selection of fluorescent CF Dyes an
Cayman Chemical 4oxo27TBDMS WIthaferIn A 10mg
A derivative of withaferin A; is cytotoxic to A2780 ovarian cancer cells (IC50 = 17 µM); selective for A2780 cells over non-cancerous ARPE19 cells (IC50 = 1,660 µM); induces DNA fragmentation in A2780 cells